Disease Characteristics and International Prognostic Scoring Systems (IPSS, IPSS-R, IPSS-M) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Participating in Two Randomized, Double-Blind, Placebo-Controlled Studies with Intravenous Sabatolimab Added to Hypomethylating Agents (HMA) (STIMULUS-MDS1 and MDS2)

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 1340 - 1342
Main Authors Santini, Valeria, Platzbecker, Uwe, Fenaux, Pierre, Giagounidis, Aristoteles, Miyazaki, Yasushi, Sekeres, Mikkael A., Xiao, Zhijian, Sanz, Guillermo, Van Hoef, Marlies, Ma, Fei, Hertle, Sabine, Marques Ramos, Pedro, Zeidan, Amer M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-160282